Income Statement Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:19:41 11/07/2025 pm IST			5-day change	1st Jan Change
1,803.30 ^INR	-0.29%		+3.78%	-18.43%

08/07	Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025
02/07	Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited	CI

433f343e19c8107667d66948e6369.XH_Y35yfSvUc8irvwWz0zQoo58U5kmulRmEMiJOzOkg.P0eXkfn8MIdptkerngOmp1l6nZdj6iDHdQ14_uT1XhwvCum7-c1-jWuBcw

Published financial data: CONCORD BIOTECH LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	512.33Cr	616.4Cr	712.93Cr	853.17Cr	1.02TCr
Total Revenues	512.33Cr	616.4Cr	712.93Cr	853.17Cr	1.02TCr
Cost of Goods Sold, Total	138.08Cr	116.94Cr	171.92Cr	192.08Cr	244.78Cr
Gross Profit	374.25Cr	499.46Cr	541.01Cr	661.09Cr	772.16Cr
Selling General & Admin Expenses, Total	67Cr	70Cr	96Cr	110.29Cr	123.07Cr
Provision for Bad Debts	17.43L	48.85L	-	-	-
Depreciation & Amortization - (IS)	21Cr	28Cr	50Cr	54Cr	54Cr
Other Operating Expenses	92Cr	99Cr	166.25Cr	197.34Cr	208.73Cr
Other Operating Expenses, Total	180.25Cr	197.22Cr	311.99Cr	361.66Cr	385.39Cr
Operating Income	194Cr	302.24Cr	229.02Cr	299.42Cr	386.76Cr
Interest Expense, Total	-69.82L	-52.32L	-5.48Cr	-4.51Cr	-2.55Cr
Interest And Investment Income	8L	1.79Cr	4.79Cr	4.44Cr	3.04Cr
Net Interest Expenses	-62.21L	1.26Cr	-69.7L	-7L	48.92L
Income (Loss) On Equity Invest.	14.96L	-44.91L	-3.64Cr	1.96Cr	3.37Cr
Currency Exchange Gains (Loss)	7.36Cr	1.55Cr	6.36Cr	10Cr	6.48Cr
Other Non Operating Income (Expenses)	28.48L	1.12Cr	97.3L	6.2Cr	1.24Cr
EBT, Excl. Unusual Items	201.17Cr	305.73Cr	232.02Cr	317.74Cr	398.35Cr
Gain (Loss) On Sale Of Investments	12Cr	6.99Cr	5.23Cr	3.72Cr	14Cr
Gain (Loss) On Sale Of Assets	5L	-	-3L	-9L	1L
Insurance Settlements	41T	29T	30.3L	65.1L	14.14L
EBT, Incl. Unusual Items	213.64Cr	312.72Cr	237.52Cr	322.01Cr	412.56Cr
Income Tax Expense	45Cr	78Cr	63Cr	82Cr	104.46Cr
Earnings From Continuing Operations	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Net Income to Company	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Net Income - (IS)	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Net Income to Common Incl Extra Items	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Net Income to Common Excl. Extra Items	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Per Share Items
Net EPS - Basic	16.17	22.45	16.72	22.95	29.45
Basic EPS - Continuing Operations	16.17	22.45	16.72	22.95	29.45
Basic Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Net EPS - Diluted	16.17	22.45	16.72	22.95	29.45
Diluted EPS - Continuing Operations	16.17	22.45	16.72	22.95	29.45
Diluted Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Normalized Basic EPS	12.02	18.26	13.86	18.98	23.8
Normalized Diluted EPS	12.02	18.26	13.86	18.98	23.8
Dividend Per Share	4.11	6.74	5.12	6.83	8.75
Payout Ratio	39.51	2.43	40.31	22.31	23.19
Supplemental Items
EBITDA	214.05Cr	328.57Cr	277.82Cr	352.21Cr	438.62Cr
EBITA	194Cr	305.34Cr	232.26Cr	302.66Cr	387.05Cr
EBIT	194Cr	302.24Cr	229.02Cr	299.42Cr	386.76Cr
EBITDAR	214.05Cr	328.57Cr	277.82Cr	352.22Cr	438.64Cr
Total Revenues (As Reported)	543.7Cr	630.51Cr	736.35Cr	888.48Cr	1.05TCr
Effective Tax Rate - (Ratio)	20.84	24.89	26.35	25.44	25.32
Total Current Taxes	54Cr	76Cr	58Cr	80Cr	100Cr
Total Deferred Taxes	-10Cr	2.34Cr	3.7Cr	2.38Cr	4.63Cr
Normalized Net Income	125.73Cr	191.08Cr	145.01Cr	198.59Cr	248.97Cr
Interest on Long-Term Debt	48.76L	39.86L	31.4L	18.19L	2.28Cr
Non-Cash Pension Expense	-54T	1L	2L	6L	4L
Supplemental Operating Expense Items
Marketing Expenses	4.27Cr	93.27L	-	-	-
Selling and Marketing Expenses	4.27Cr	93.27L	-	-	-
Research And Development Expense From Footnotes	-	-	-	33Cr	23Cr
Net Rental Expense, Total	24T	44T	20T	71T	2L
Imputed Operating Lease Interest Expense	-	2.61T	11.56T	54.48T	2L
Imputed Operating Lease Depreciation	-	41.39T	8.44T	16.52T	2.2T
Maintenance & Repair Expenses, Total	8.14Cr	5.37Cr	7.91Cr	12Cr	16Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.41Cr	5.14Cr	66.7L	3.5Cr	15Cr
Short Term Investments	-	55Cr	87Cr	31Cr	23Cr
Trading Asset Securities, Total	198.11Cr	140.99Cr	73Cr	136.93Cr	243.7Cr
Total Cash And Short Term Investments	200.51Cr	201.13Cr	161.39Cr	171.01Cr	281.67Cr
Accounts Receivable, Total	183.5Cr	177.52Cr	232.17Cr	273.76Cr	349.61Cr
Other Receivables	13Cr	36Cr	27Cr	22Cr	16Cr
Total Receivables	196.88Cr	213.34Cr	259.45Cr	295.55Cr	365.61Cr
Inventory	111.23Cr	153.61Cr	195.12Cr	212.31Cr	207.95Cr
Prepaid Expenses	4.02Cr	4.54Cr	4.76Cr	5.52Cr	7.33Cr
Other Current Assets, Total	26Cr	35Cr	12Cr	43Cr	34Cr
Total Current Assets	538.79Cr	607.14Cr	632.67Cr	727.7Cr	896.23Cr
Gross Property Plant And Equipment	450.1Cr	650.16Cr	781.4Cr	952.79Cr	1.02TCr
Accumulated Depreciation	-69Cr	-92Cr	-137.85Cr	-187.31Cr	-238.46Cr
Net Property Plant And Equipment	380.91Cr	557.75Cr	643.56Cr	765.48Cr	786.48Cr
Long-term Investments	81.48L	36.57L	25.6L	12.46L	2.07Cr
Other Intangibles, Total	9L	6.42Cr	3.58Cr	19.77L	31.97L
Other Long-Term Assets, Total	20Cr	11Cr	33Cr	20Cr	16Cr
Total Assets	940.72Cr	1.18TCr	1.31TCr	1.51TCr	1.7TCr
Liabilities
Accounts Payable, Total	71Cr	46Cr	83Cr	94Cr	94Cr
Accrued Expenses, Total	7.56Cr	10Cr	13Cr	15Cr	17Cr
Short-term Borrowings	-	5.1Cr	4.34Cr	-	-
Current Portion of Long-Term Debt	12Cr	25Cr	25Cr	25Cr	6.23Cr
Current Portion of Leases	1.09Cr	1.3Cr	1.6Cr	14.69L	1.62Cr
Current Income Taxes Payable	1.79Cr	-	-	9Cr	5.49Cr
Unearned Revenue Current, Total	-	-	3.27Cr	1.31Cr	-
Other Current Liabilities	21Cr	18Cr	25Cr	48Cr	18Cr
Total Current Liabilities	115.31Cr	105.74Cr	155.17Cr	191.84Cr	142.16Cr
Long-Term Debt	36Cr	56Cr	31Cr	6.24Cr	-
Long-Term Leases	2.93Cr	1.63Cr	31.1L	16.38L	1.89Cr
Deferred Tax Liability Non Current	15Cr	17Cr	21Cr	23Cr	28Cr
Other Non Current Liabilities	1.59Cr	2.1Cr	1.87Cr	2.3Cr	1.96Cr
Total Liabilities	170.49Cr	183.17Cr	209.57Cr	223.98Cr	174.06Cr
Common Stock, Total	9.51Cr	9.51Cr	9.51Cr	10Cr	10Cr
Additional Paid In Capital	83Cr	83Cr	83Cr	82Cr	82Cr
Retained Earnings	677.8Cr	906.94Cr	1.01TCr	1.2TCr	1.43TCr
Total Common Equity	770.23Cr	999.37Cr	1.1TCr	1.29TCr	1.53TCr
Total Equity	770.23Cr	999.37Cr	1.1TCr	1.29TCr	1.53TCr
Total Liabilities And Equity	940.72Cr	1.18TCr	1.31TCr	1.51TCr	1.7TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10Cr	10Cr	10Cr	10Cr	10Cr
ECS Total Common Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Book Value / Share	73.62	95.53	105.45	123.31	145.93
Tangible Book Value	770.14Cr	992.95Cr	1.1TCr	1.29TCr	1.53TCr
Tangible Book Value Per Share	73.62	94.91	105.11	123.29	145.9
Total Debt	52Cr	89Cr	62Cr	32Cr	9.74Cr
Net Debt	-148.46Cr	-111.85Cr	-99Cr	-139.46Cr	-271.93Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	17.71L	22.13L	93.5L	57.67L	42.7L
Debt Equivalent Oper. Leases	2L	4L	2L	6L	16L
Equity Method Investments, Total	81.48L	36.57L	-	-	2.06Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	61Cr	65Cr	81Cr	80Cr	63Cr
Inventories - Work In Process, Total	39Cr	68Cr	90Cr	113.2Cr	123.48Cr
Inventories - Finished Goods, Total	10Cr	20Cr	22Cr	15Cr	17Cr
Inventories - Others	74.21L	58.4L	1.94Cr	3.89Cr	4.57Cr
Land - (BS)	54Cr	55Cr	55Cr	55Cr	55Cr
Buildings, Total	74Cr	198.08Cr	222.63Cr	246.29Cr	257.57Cr
Machinery, Total	177.62Cr	377.28Cr	428.54Cr	478.83Cr	497.91Cr
Full Time Employees	-	-	1.18T	-	1.38T
Accumulated Allowance for Doubtful Accounts (Supple)	1.16Cr	1.13Cr	78.1L	87.3L	1.39Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	169.11Cr	234.89Cr	174.93Cr	240.09Cr	308.1Cr
Depreciation & Amortization - CF	21Cr	24Cr	47Cr	51Cr	53Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	3.1Cr	3.24Cr	3.24Cr	28.99L
Depreciation & Amortization, Total	21Cr	27Cr	50Cr	54Cr	54Cr
Amortization of Deferred Charges, Total - (CF)	15.74L	15.41L	15.5L	13.89L	5L
(Gain) Loss From Sale Of Asset	-5L	-	3L	9L	-1L
(Gain) Loss on Sale of Investments - (CF)	-12Cr	-6.99Cr	-5.23Cr	-3.72Cr	-14Cr
(Income) Loss On Equity Investments - (CF)	-	44.91L	3.64Cr	-1.96Cr	-3.37Cr
Provision and Write-off of Bad Debts	62.07L	45.99L	-34.6L	9L	66.94L
Other Operating Activities, Total	-1.71Cr	-75.15L	6.45Cr	12Cr	1.73Cr
Change In Accounts Receivable	-30Cr	6.5Cr	-53Cr	-43Cr	-79Cr
Change In Inventories	-20Cr	-42Cr	-42Cr	-17Cr	4.36Cr
Change In Accounts Payable	39Cr	-23Cr	37Cr	9.88Cr	-11Cr
Change in Other Net Operating Assets	-12Cr	-30Cr	36Cr	-1.84Cr	4.41Cr
Cash from Operations	155.09Cr	166.81Cr	207.48Cr	248.3Cr	265.47Cr
Capital Expenditure	-156.5Cr	-204.42Cr	-155.5Cr	-145.08Cr	-86Cr
Sale of Property, Plant, and Equipment	17.03L	-	6L	3L	17.51L
Investment in Marketable and Equity Securities, Total	42Cr	8.87Cr	40Cr	-18Cr	-72Cr
Other Investing Activities, Total	4L	10.7L	4.14Cr	5.58Cr	2.77Cr
Cash from Investing	-113.93Cr	-195.44Cr	-111.79Cr	-157.95Cr	-154.61Cr
Short Term Debt Issued, Total	-	5.1Cr	-	-	-
Long-Term Debt Issued, Total	48Cr	52Cr	-	-	-
Total Debt Issued	48Cr	57Cr	-	-	-
Short Term Debt Repaid, Total	-	-	-76.1L	-	-
Long-Term Debt Repaid, Total	-9.71Cr	-20Cr	-27Cr	-27Cr	-27Cr
Total Debt Repaid	-9.71Cr	-20Cr	-27Cr	-27Cr	-27Cr
Common Dividends Paid	-67Cr	-5.71Cr	-71Cr	-54Cr	-71Cr
Common & Preferred Stock Dividends Paid	-67Cr	-5.71Cr	-71Cr	-54Cr	-71Cr
Other Financing Activities, Total	-14Cr	-15.75L	-2.23Cr	-54.07L	-1.26Cr
Cash from Financing	-43Cr	31Cr	-100.16Cr	-81Cr	-99Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-6.63Cr	-
Net Change in Cash	-1.35Cr	2.74Cr	-4.48Cr	2.83Cr	12Cr
Supplemental Items
Cash Interest Paid	29.04L	15.75L	5.32Cr	3.78Cr	2.65Cr
Cash Income Tax Paid (Refund)	49Cr	75Cr	61Cr	70Cr	103.35Cr
Levered Free Cash Flow	-	-83Cr	19Cr	50Cr	117.77Cr
Unlevered Free Cash Flow	-	-83Cr	22Cr	53Cr	119.36Cr
Change In Net Working Capital	-	95Cr	15Cr	43Cr	90Cr
Net Debt Issued / Repaid	38Cr	37Cr	-27Cr	-27Cr	-27Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	-	17.8	11.47	13.24	15.04
Return on Total Capital	-	19.77	12.7	15.05	16.92
Return On Equity %	-	26.55	16.64	20.06	21.88
Return on Common Equity	-	26.55	16.64	20.06	21.88
Margin Analysis
Gross Profit Margin %	73.05	81.03	75.89	77.49	75.93
SG&A Margin	12.98	11.42	13.42	12.93	12.1
EBITDA Margin %	41.78	53.3	38.97	41.28	43.13
EBITA Margin %	37.87	49.54	32.58	35.48	38.06
EBIT Margin %	37.87	49.03	32.12	35.1	38.03
Income From Continuing Operations Margin %	33.01	38.11	24.54	28.14	30.3
Net Income Margin %	33.01	38.11	24.54	28.14	30.3
Net Avail. For Common Margin %	33.01	38.11	24.54	28.14	30.3
Normalized Net Income Margin	24.54	31	20.34	23.28	24.48
Levered Free Cash Flow Margin	-	-13.54	2.65	5.9	11.58
Unlevered Free Cash Flow Margin	-	-13.48	3.13	6.23	11.74
Asset Turnover
Asset Turnover	-	0.58	0.57	0.6	0.63
Fixed Assets Turnover	-	1.31	1.19	1.21	1.31
Receivables Turnover (Average Receivables)	-	3.41	3.48	3.37	3.26
Inventory Turnover (Average Inventory)	-	0.88	0.99	0.94	1.16
Short Term Liquidity
Current Ratio	4.67	5.74	4.08	3.79	6.3
Quick Ratio	3.45	3.92	2.71	2.43	4.55
Operating Cash Flow to Current Liabilities	1.35	1.58	1.34	1.29	1.87
Days Sales Outstanding (Average Receivables)	-	106.89	104.87	108.22	112.18
Days Outstanding Inventory (Average Inventory)	-	413.31	370.19	387.11	314.19
Average Days Payable Outstanding	-	134.75	110.74	154.27	143.28
Cash Conversion Cycle (Average Days)	-	385.45	364.33	341.06	283.09
Long Term Solvency
Total Debt/Equity	6.76	8.93	5.66	2.45	0.64
Total Debt / Total Capital	6.33	8.2	5.36	2.39	0.63
LT Debt/Equity	4.99	5.79	2.86	0.5	0.12
Long-Term Debt / Total Capital	4.68	5.32	2.71	0.48	0.12
Total Liabilities / Total Assets	18.12	15.49	15.96	14.79	10.23
EBIT / Interest Expense	277.86	577.67	41.76	66.39	151.56
EBITDA / Interest Expense	308.06	629.98	50.86	78.34	172.54
(EBITDA - Capex) / Interest Expense	83.91	239.28	22.5	46.17	138.96
Total Debt / EBITDA	0.24	0.27	0.22	0.09	0.02
Net Debt / EBITDA	-0.69	-0.34	-0.35	-0.39	-0.62
Total Debt / (EBITDA - Capex)	0.89	0.71	0.51	0.15	0.03
Net Debt / (EBITDA - Capex)	-2.53	-0.89	-0.8	-0.67	-0.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	20.31	15.56	19.67	19.2
Gross Profit, 1 Yr. Growth %	-	33.46	8.2	22.19	16.8
EBITDA, 1 Yr. Growth %	-	53.5	-15.48	26.78	24.38
EBITA, 1 Yr. Growth %	-	57.39	-23.97	30.31	27.7
EBIT, 1 Yr. Growth %	-	55.79	-24.26	30.74	28.98
Earnings From Cont. Operations, 1 Yr. Growth %	-	38.89	-25.53	37.25	28.33
Net Income, 1 Yr. Growth %	-	38.89	-25.53	37.25	28.33
Normalized Net Income, 1 Yr. Growth %	-	51.98	-24.11	36.94	25.36
Diluted EPS Before Extra, 1 Yr. Growth %	-	38.89	-25.52	37.25	28.33
Accounts Receivable, 1 Yr. Growth %	-	-3.26	30.79	17.91	27.71
Inventory, 1 Yr. Growth %	-	38.1	27.02	8.81	-2.05
Net Property, Plant and Equip., 1 Yr. Growth %	-	46.42	15.38	18.95	2.74
Total Assets, 1 Yr. Growth %	-	25.73	11.01	15.33	12.33
Tangible Book Value, 1 Yr. Growth %	-	28.93	10.74	17.29	18.34
Common Equity, 1 Yr. Growth %	-	29.75	10.39	16.93	18.34
Cash From Operations, 1 Yr. Growth %	-	7.76	24.37	19.29	7.91
Capital Expenditures, 1 Yr. Growth %	-	31.49	-23.84	-6.7	-40.94
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-122.71	166.37	132.77
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-126.96	138.1	123.47
Dividend Per Share, 1 Yr. Growth %	-	63.87	-24.05	33.4	28.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	17.96	17.6	19.43
Gross Profit, 2 Yr. CAGR %	-	-	20.23	14.99	19.47
EBITDA, 2 Yr. CAGR %	-	-	13.93	3.51	25.65
EBITA, 2 Yr. CAGR %	-	-	9.42	-0.46	29.09
EBIT, 2 Yr. CAGR %	-	-	8.65	-0.49	29.95
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	1.71	1.1	32.71
Net Income, 2 Yr. CAGR %	-	-	1.71	1.1	32.71
Normalized Net Income, 2 Yr. CAGR %	-	-	7.4	1.94	31.03
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	1.7	1.11	32.71
Accounts Receivable, 2 Yr. CAGR %	-	-	12.48	24.18	22.71
Inventory, 2 Yr. CAGR %	-	-	32.44	17.57	3.24
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	29.98	17.15	10.55
Total Assets, 2 Yr. CAGR %	-	-	18.14	13.15	13.82
Tangible Book Value, 2 Yr. CAGR %	-	-	19.49	13.97	17.81
Common Equity, 2 Yr. CAGR %	-	-	19.68	13.61	17.64
Cash From Operations, 2 Yr. CAGR %	-	-	15.75	22	12.93
Capital Expenditures, 2 Yr. CAGR %	-	-	0.01	-15.7	-25.77
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-22.23	149.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-19.88	131.27
Dividend Per Share, 2 Yr. CAGR %	-	-	11.56	0.66	30.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	18.53	18.13
Gross Profit, 3 Yr. CAGR %	-	-	-	20.88	15.59
EBITDA, 3 Yr. CAGR %	-	-	-	18.06	10.09
EBITA, 3 Yr. CAGR %	-	-	-	15.98	8.21
EBIT, 3 Yr. CAGR %	-	-	-	15.57	8.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	12.39	9.47
Net Income, 3 Yr. CAGR %	-	-	-	12.39	9.47
Normalized Net Income, 3 Yr. CAGR %	-	-	-	16.46	9.22
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	12.39	9.47
Accounts Receivable, 3 Yr. CAGR %	-	-	-	14.26	25.35
Inventory, 3 Yr. CAGR %	-	-	-	24.05	10.62
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	26.19	12.14
Total Assets, 3 Yr. CAGR %	-	-	-	17.2	12.88
Tangible Book Value, 3 Yr. CAGR %	-	-	-	18.75	15.41
Common Equity, 3 Yr. CAGR %	-	-	-	18.76	15.17
Cash From Operations, 3 Yr. CAGR %	-	-	-	17.05	16.75
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-2.28	-25.13
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	12.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	12.98
Dividend Per Share, 3 Yr. CAGR %	-	-	-	18.41	9.08